# TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis

> **NCT01556282** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 35 (actual)

## Conditions studied

- Liver Cancer
- Portal Vein Thrombosis

## Interventions

- **DEVICE:** TheraSphere

## Key facts

- **NCT ID:** NCT01556282
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01556282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01556282, "TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01556282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*